Ingalls & Snyder LLC’s Elanco Animal Health ELAN Stock Holding History

Ingalls & Snyder LLC’s Portfolio ELAN Stock Details ELAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-27,003	Closed	-$530K	–	445
2022 Q2	$530K	Sell	27,003 -2,123	-7%	-$50.2K	0.03%	272
2022 Q1	$760K	Sell	29,126 -2,893	-9%	-$77K	0.03%	258
2021 Q4	$909K	Sell	32,019 -6,144	-16%	-$191K	0.04%	245
2021 Q3	$1.22M	Sell	38,163 -1,420	-4%	-$47.6K	0.06%	215
2021 Q2	$1.37M	Sell	39,583 -3,050	-7%	-$101K	0.06%	205
2021 Q1	$1.26M	Sell	42,633 -950	-2%	-$29.2K	0.06%	210
2020 Q4	$1.34M	Sell	43,583 -3,100	-7%	-$94.6K	0.07%	190
2020 Q3	$1.3M	Sell	46,683 -1,050	-2%	-$26.6K	0.09%	157
2020 Q2	$1.02M	Sell	47,733 -1,200	-2%	-$26.5K	0.06%	196
2020 Q1	$1.1M	Sell	48,933 -850	-2%	-$23.3K	0.07%	186
2019 Q4	$1.47M	Sell	49,783 -1,760	-3%	-$47.8K	0.08%	162
2019 Q3	$1.37M	Buy	+51,543	New	+$1.55M	0.07%	185

Other funds holding ELAN

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

SHCM

Sachem Head Capital Management New York $4.82B AUM 73.38% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Amundi Paris, France $416B AUM 44.19% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Ingalls & Snyder LLC's ELAN Position: Q3 2022 in Review

Ingalls & Snyder LLC sold out of Elanco Animal Health (ELAN) in Q3 2022, closing a stake of 27,003 shares — an estimated $530K sold.

Ingalls & Snyder LLC first reported a position in ELAN in Q3 2019 and held it in 12 quarters. The position peaked at $1.47M in Q4 2019. 419 funds tracked by Wall St. Rank hold ELAN as of Q3 2022.

Ingalls & Snyder LLC reported no remaining Elanco Animal Health position as of Q3 2022 after selling out during the quarter.
Ingalls & Snyder LLC sold 27,003 Elanco Animal Health shares in Q3 2022, an estimated $530K.
Ingalls & Snyder LLC first reported a position in Elanco Animal Health in Q3 2019 and held it in 12 quarters.
Ingalls & Snyder LLC's Elanco Animal Health position peaked at $1.47M in Q4 2019.
419 funds tracked by Wall St. Rank held Elanco Animal Health as of Q3 2022.

Based on Ingalls & Snyder LLC's 13F filing for Q3 2022, filed 21 Oct 2022.